Blue Owl Capital Holdings »

Pyxis Oncology shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.5M 1.0M 3.31

More positions owned by Blue Owl Capital Holdings

Cullinan Oncology (CGEM)
Pliant Therapeutics (PLRX)
Owl Rock Capital Corporation (OBDC)
Klaviyo Com Ser A (KVYO)
Larimar Therapeutics (LRMR)
Engene Holdings (ENGN)
Tourmaline Bio (TRML)
Evercommerce (EVCM)
Acelyrin (SLRN)
Repare Therapeutics Ord (RPTX)
Ultragenyx Pharmaceutical (RARE)
Context Therapeutics (CNTX)
Disc Medicine (IRON)
Toast Cl A (TOST)
E2open Parent Holdings Com Cl A (ETWO)

View all positions for Blue Owl Capital Holdings

Top funds holding Pyxis Oncology

Deep Track Capital
Laurion Capital Management
BlackRock
Balyasny Asset Management
Vanguard Group
Ikarian Capital
Millennium Management
Stempoint Capital
Blue Owl Capital Holdings
Geode Capital Management
State Street Corporation
Standard Life Aberdeen
Boothbay Fund Management
Superstring Capital Management
Hillhouse Capital Advisors

View all funds holding Pyxis Oncology